Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.
about
Second-generation inhibitors of Bruton tyrosine kinaseChemically Programmed Bispecific Antibodies in Diabody Format.Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulationBruton tyrosine kinase inhibitor ONO/GS-4059: from bench to bedside.Antibody mimicry, receptors and clinical applications.Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment.Current progress in innovative engineered antibodies.The making of bispecific antibodiesComputational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.Mass spectrometric characterization of protein structures and protein complexes in condensed and gas phase.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Kinetic mechanism of controlled Fab-arm exchange for the formation of bispecific immunoglobulin G1 antibodies.Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening.New Chimeric Antigen Receptor Design for Solid Tumors.Recent advances in automated protein design and its future challenges.EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma.Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeuticsCAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell GrowthMolecular Imaging of Radiolabeled Bispecific T-Cell Engager Zr-AMG211 Targeting CEA-Positive TumorsDevelopment of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agentsDuokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans
P2860
Q28076118-1E3A4045-EB77-4D20-B036-4010309FBAAFQ38436973-FDA741A4-151B-4823-9889-4DEFCC8685B0Q38974641-652C02B0-5289-427A-9F63-F68E71AFFFDDQ38989496-CC92D66E-6BAE-4869-8DC5-3B5712D0648FQ39062940-A3DFF2CF-6B8A-4886-AFB2-D57AB401638CQ39194733-ECB88627-1E96-4809-A00B-A27FD696676FQ40077818-7D6EE82E-8DC1-4CA5-AC67-9D3B96FFABBDQ42323236-68F5710F-AF2E-4E0B-915A-707C2E80A855Q45037117-8EF65CE2-E654-40C5-87F3-595BF1477D91Q46219687-A14B36F2-8F72-40EE-A5A3-0B0DA3A9FEA3Q47221234-5A893EE6-C4C3-4E04-81DA-C11E3A05BCA2Q47336563-BB625956-EAE1-4568-BE65-FB7E9D295279Q47594827-450181A1-3386-471A-BACC-AC1B54B04A90Q49711158-926600F7-B0A6-4AD9-825F-A6C11B0E784DQ52309659-F226D6A6-6C52-479E-AD39-66B9AE48ACD7Q55689740-9F5AC2E9-E13A-4CE4-B7BD-981C8CE2A455Q57151874-64C4F6FD-F5B4-4A2E-B359-D28B6AF64DF9Q57158297-020E6436-4FE7-476D-99C2-46ACC21984D7Q57462228-2D7BFE8E-3F44-4DF8-B27C-BFC6B7B73390Q58726545-56554F53-25C1-468F-BEC7-26FD7CA7007BQ58804320-31290218-7FEF-4419-9D0D-40A09D250676
P2860
Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@ast
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@en
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@nl
type
label
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@ast
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@en
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@nl
prefLabel
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@ast
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@en
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@nl
P2860
P1476
Bispecific antibodies and CARs ...... harnessing T cell redirection.
@en
P2093
Eugene A Zhukovsky
Richard J Morse
P2860
P356
10.1016/J.COI.2016.02.006
P577
2016-03-07T00:00:00Z